Bylvay vs Livmarli: Side-by-Side Comparison
Quick answer: Bylvay and Livmarli are both ileal bile acid transporter (ibat) inhibitor used for similar indications. They share a mechanism of action but differ in dosing, half-life, side-effect profile, and clinical preferences. Switching between them is a clinical decision.
Side-by-side comparison
| Feature | Bylvay | Livmarli |
|---|---|---|
| Drug class | Ileal bile acid transporter (IBAT) inhibitor | Ileal bile acid transporter (IBAT) inhibitor |
| ATC code | A05AX05 | A05AX05 |
| Primary indications | Progressive familial intrahepatic cholestasis, Alagille syndrome pruritus | Cholestatic pruritus in Alagille syndrome, Progressive familial intrahepatic cholestasis |
| Mechanism | Odevixibat; inhibits ileal bile acid transporter reducing bile acid reabsorption | Maralixibat reversibly inhibits the ileal bile acid transporter, reducing bile acid reabsorption and serum bile acid levels |
| Common dose | 40-120 mcg/kg once daily | 190-380 mcg/kg once daily |
| Detail page | Bylvay details → | Livmarli details → |
How to choose between Bylvay and Livmarli
Both medicines belong to the same therapeutic class and address overlapping indications. Selection between them depends on:
- Patient-specific factors: age, kidney and liver function, other medications, allergies, comorbidities
- Specific clinical indication: some class members are preferred for particular conditions or guideline recommendations
- Dosing preference: once-daily vs twice-daily, oral vs injectable, food requirements
- Tolerability: individual side-effect profiles vary even within a class
- Drug interactions: patient's other medications may interact differently with each option
- Cost and availability: generic availability, insurance coverage, regional access
Should you switch?
Switching between class members is a clinical decision, not a self-help one. Reasons your prescriber may consider switching include:
- Inadequate response to current medication
- Side effects affecting quality of life
- New drug interactions due to a recently added medication
- Cost or availability changes
- Updated guidelines favoring a different option
Never switch medications, change dose, or stop without consulting your prescriber.
Related
All Ileal bile acid transporter (IBAT) inhibitor on iMedic · Bylvay full details · Livmarli full details
Frequently asked questions
Is Bylvay better than Livmarli?
Neither is universally 'better.' They are both ileal bile acid transporter (ibat) inhibitor with similar mechanisms of action. The right choice depends on the specific clinical situation, patient factors, dosing preferences, drug interactions, and tolerability. Discuss with your prescriber.
Can I switch from Bylvay to Livmarli?
Switching is possible but should be done under clinical supervision. Different class members may not be interchangeable on a 1:1 dose basis, and tapering or transition strategies vary. Never switch on your own.
Do Bylvay and Livmarli have the same side effects?
They share class-wide side-effect tendencies but differ in individual profiles. Some patients tolerate one better than the other. Specific frequency and severity of side effects can be found on each medicine's individual page.
Are Bylvay and Livmarli available as generics?
Generic availability depends on patent status in your country. Most well-established class members are available generically and are clinically equivalent to brand-name versions.
Last reviewed: by iMedic Medical Editorial Team. Our editorial process.